163 related articles for article (PubMed ID: 37482497)
1. The trajectory of sarcopenia following diagnosis of prostate cancer: A systematic review and meta-analysis.
Kovač MB; Pavlin T; Čavka L; Ribnikar D; Spazzapan S; Templeton AJ; Šeruga B
J Geriatr Oncol; 2023 Sep; 14(7):101594. PubMed ID: 37482497
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenic Obesity and its Prognostic Impact on Urological Cancers: A Systematic Review.
Stangl-Kremser J; Mari A; Lai LY; Lee CT; Vince R; Zaslavsky A; Salami SS; Fajkovic H; Shariat SF; Palapattu GS
J Urol; 2021 Oct; 206(4):854-865. PubMed ID: 34032495
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of sarcopenia in patients with metastatic hormone-sensitive prostate cancer.
Ikeda T; Ishihara H; Iizuka J; Hashimoto Y; Yoshida K; Kakuta Y; Takagi T; Okumi M; Ishida H; Kondo T; Tanabe K
Jpn J Clin Oncol; 2020 Aug; 50(8):933-939. PubMed ID: 32303747
[TBL] [Abstract][Full Text] [Related]
4. Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.
Xu MC; Huelster HL; Hatcher JB; Avulova S; Stocks BT; Glaser ZA; Moses KA; Silver HJ
J Urol; 2021 Mar; 205(3):800-805. PubMed ID: 33080148
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and prognostic value of sarcopenic obesity in patients with cancer: A systematic review and meta-analysis.
Gao Q; Hu K; Gao J; Shang Y; Mei F; Zhao L; Chen F; Ma B
Nutrition; 2022 Sep; 101():111704. PubMed ID: 35696740
[TBL] [Abstract][Full Text] [Related]
6. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
[TBL] [Abstract][Full Text] [Related]
7. The role of sarcopenia in treatment-related outcomes in patients with renal cell carcinoma: A systematic review and meta-analysis.
Yuxuan L; Junchao L; Wenya L
Medicine (Baltimore); 2022 Oct; 101(43):e31332. PubMed ID: 36316941
[TBL] [Abstract][Full Text] [Related]
8. Impact of sarcopenia and sarcopenic obesity on survival in patients with primary liver cancer: a systematic review and meta-analysis.
Li X; Huang X; Lei L; Tong S
Front Nutr; 2023; 10():1233973. PubMed ID: 37927508
[TBL] [Abstract][Full Text] [Related]
9. The influence process of sarcopenia on female cancer: A systematic review and meta-analysis.
Li YX; Xia WW; Liu WY
J Obstet Gynaecol Res; 2021 Dec; 47(12):4403-4413. PubMed ID: 34496449
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenia as a predictor of postoperative outcomes after urologic oncology surgery: A systematic review and meta-analysis.
Guo Z; Gu C; Gan S; Li Y; Xiang S; Gong L; Chan FL; Wang S
Urol Oncol; 2020 Jun; 38(6):560-573. PubMed ID: 32268990
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta-analysis.
Mintziras I; Miligkos M; Wächter S; Manoharan J; Maurer E; Bartsch DK
Int J Surg; 2018 Nov; 59():19-26. PubMed ID: 30266663
[TBL] [Abstract][Full Text] [Related]
12. Preoperative sarcopenia is a predictor of poor prognosis of esophageal cancer after esophagectomy: a comprehensive systematic review and meta-analysis.
Deng HY; Zha P; Peng L; Hou L; Huang KL; Li XY
Dis Esophagus; 2019 Mar; 32(3):. PubMed ID: 30496385
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta-analysis.
Fang P; Zhou J; Xiao X; Yang Y; Luan S; Liang Z; Li X; Zhang H; Shang Q; Zeng X; Yuan Y
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):3-16. PubMed ID: 36415154
[TBL] [Abstract][Full Text] [Related]
14. PITX2 methylation: a novel and effective biomarker for monitoring biochemical recurrence risk of prostate cancer.
Jiang Q; Xie M; He M; Yan F; Chen M; Xu S; Zhang X; Shen P
Medicine (Baltimore); 2019 Jan; 98(1):e13820. PubMed ID: 30608394
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of Sarcopenia in Patients with Advanced Prostate Carcinoma: A Systematic Review.
de Pablos-Rodríguez P; Del Pino-Sedeño T; Infante-Ventura D; de Armas-Castellano A; Ramírez Backhaus M; Ferrer JFL; de Pablos-Velasco P; Rueda-Domínguez A; Trujillo-Martín MM
J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614862
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia predicts worse postoperative outcomes and decreased survival rates in patients with colorectal cancer: a systematic review and meta-analysis.
Trejo-Avila M; Bozada-Gutiérrez K; Valenzuela-Salazar C; Herrera-Esquivel J; Moreno-Portillo M
Int J Colorectal Dis; 2021 Jun; 36(6):1077-1096. PubMed ID: 33481108
[TBL] [Abstract][Full Text] [Related]
17. Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta-analysis.
Takenaka Y; Oya R; Takemoto N; Inohara H
J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1122-1135. PubMed ID: 34337889
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III.
Batsis JA; Mackenzie TA; Barre LK; Lopez-Jimenez F; Bartels SJ
Eur J Clin Nutr; 2014 Sep; 68(9):1001-7. PubMed ID: 24961545
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the "obesity paradox" in the elderly: A systematic review and meta-analysis of sarcopenic obesity.
Liu C; Wong PY; Chung YL; Chow SK; Cheung WH; Law SW; Chan JCN; Wong RMY
Obes Rev; 2023 Feb; 24(2):e13534. PubMed ID: 36443946
[TBL] [Abstract][Full Text] [Related]
20. Association between sarcopenia and prognosis of hepatocellular carcinoma: A systematic review and meta-analysis.
Jiang C; Wang Y; Fu W; Zhang G; Feng X; Wang X; Wang F; Zhang L; Deng Y
Front Nutr; 2022; 9():978110. PubMed ID: 36590214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
